GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » Inventories, Finished Goods

CSL (CMXHF) Inventories, Finished Goods : $0 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is CSL Inventories, Finished Goods?

CSL's quarterly finished goods increased from Dec. 2022 ($0 Mil) to Jun. 2023 ($1,755 Mil) but then declined from Jun. 2023 ($1,755 Mil) to Dec. 2023 ($0 Mil).

CSL's annual finished goods declined from Jun. 2021 ($1,222 Mil) to Jun. 2022 ($1,218 Mil) but then increased from Jun. 2022 ($1,218 Mil) to Jun. 2023 ($1,755 Mil).

CSL Inventories, Finished Goods Historical Data

The historical data trend for CSL's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Inventories, Finished Goods Chart

CSL Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,074.40 1,271.60 1,221.90 1,218.30 1,755.00

CSL Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,218.30 - 1,755.00 -

CSL Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

CSL (CMXHF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » Inventories, Finished Goods
Comparable Companies
ASX:TLX ASX:NEU ASX:MSB ASX:CU6 ASX:CUV ASX:IMU ASX:IMM ASX:OPT ASX:PYC ASX:BOT OCSE:NOVO B VRTX REGN MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB
Traded in Other Exchanges
CSLLY:USA CSJ:Germany CSL:Australia
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
Website
https://www.csl.com
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.